Bausch Health Co. Inc. (NYSE: BHC) reported Q2 EPS of ($0.40), $1.29 worse than the analyst estimate of $0.89. Revenue for the quarter came in at $1.97 billion versus the consensus estimate of $2.03 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2022 revenue of $8.05-8.22 billion, versus the consensus of $8.34 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.